NDC 0527-3220

Dantrolene Sodium

Dantrolene Sodium

Dantrolene Sodium is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lannett Company, Inc.. The primary component is Dantrolene Sodium.

Product ID0527-3220_aa8a58a9-7696-4c26-b277-6b4f74cd020e
NDC0527-3220
Product TypeHuman Prescription Drug
Proprietary NameDantrolene Sodium
Generic NameDantrolene Sodium
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2005-10-26
Marketing CategoryANDA / ANDA
Application NumberANDA076686
Labeler NameLannett Company, Inc.
Substance NameDANTROLENE SODIUM
Active Ingredient Strength25 mg/1
Pharm ClassesDecreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0527-3220-37

100 CAPSULE in 1 BOTTLE (0527-3220-37)
Marketing Start Date2005-10-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0527-3220-37 [00527322037]

Dantrolene Sodium CAPSULE
Marketing CategoryANDA
Application NumberANDA076686
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-10-26

Drug Details

Active Ingredients

IngredientStrength
DANTROLENE SODIUM25 mg/1

OpenFDA Data

SPL SET ID:e23dcfd0-071a-4458-a595-3562fabccbd4
Manufacturer
UNII
UPC Code
  • 0305273220378
  • 0305273219372
  • 0305273221375
  • Pharmacological Class

    • Decreased Striated Muscle Contraction [PE]
    • Decreased Striated Muscle Tone [PE]
    • Skeletal Muscle Relaxant [EPC]
    • Decreased Striated Muscle Contraction [PE]
    • Decreased Striated Muscle Tone [PE]
    • Skeletal Muscle Relaxant [EPC]